Page 4 - Optimizing Therapy News Today

Explore the case of a 67-year-old patient with recurrent endometrial cancer, highlighting the importance of MMR testing, NGS, and emerging treatment options in today's landscape.

Dive into the evolving landscape of endometrial cancer, including rising incidence, classification, racial disparities, and emerging modalities, as discussed by experts Ritu Salani, MD, MBA, and Bhavana Pothuri, MD.

Explore statistics behind and possible patient presentations of advanced renal cell carcinoma (RCC), with insight into IMDC risk stratification that may influence treatment strategies and outcomes.

Expert panelists share final thoughts concerning the future of chronic GvHD treatment, highlighting unmet needs, ongoing trials, and promising therapies.

Clinical pearls for community oncologists regarding treatment selection and sequencing in chronic GvHD patients.

Addressing patient monitoring in chronic GvHD, including therapy adjustment indicators and frequency.

Exploring FDA-approved treatment options for patients with chronic GvHD, with a focus on trial data and adverse effects.

Insights on treatment strategies and goals for initial chronic GvHD management, including treatment selection rationale and dosing.

Experienced clinicians discuss the future of acute GvHD treatment, focusing on gaps in patient care and potential therapy options.

Moderator Michael Bishop, MD introduces expert panelists and leads an overview of Graft-Versus-Host Disease, covering the differences between chronic and acute conditions, how GvHD is typically diagnosed, and GvHD risk assessment.